Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaginal Smears | 71 | 2020 | 499 | 7.960 |
Why?
|
Uterine Cervical Neoplasms | 72 | 2022 | 2019 | 6.260 |
Why?
|
Uterine Cervical Dysplasia | 40 | 2022 | 384 | 5.330 |
Why?
|
Pathology, Clinical | 29 | 2021 | 376 | 4.570 |
Why?
|
Cytodiagnosis | 27 | 2018 | 447 | 3.020 |
Why?
|
Papillomavirus Infections | 29 | 2022 | 1610 | 2.830 |
Why?
|
Cervix Uteri | 22 | 2022 | 570 | 2.670 |
Why?
|
Papillomaviridae | 21 | 2013 | 1119 | 2.090 |
Why?
|
Carcinoma, Squamous Cell | 27 | 2016 | 4021 | 1.760 |
Why?
|
Cytological Techniques | 11 | 2014 | 218 | 1.710 |
Why?
|
Diagnostic Errors | 19 | 2013 | 1265 | 1.540 |
Why?
|
Telepathology | 6 | 2014 | 77 | 1.530 |
Why?
|
Uterine Cervical Diseases | 7 | 2014 | 73 | 1.500 |
Why?
|
Vaginal Neoplasms | 6 | 2014 | 104 | 1.410 |
Why?
|
Automation | 15 | 2021 | 586 | 1.360 |
Why?
|
Terminology as Topic | 11 | 2015 | 1535 | 1.190 |
Why?
|
Pathology, Surgical | 11 | 2014 | 151 | 1.180 |
Why?
|
Cell Biology | 8 | 2011 | 90 | 1.060 |
Why?
|
Quality Assurance, Health Care | 18 | 2015 | 2169 | 1.010 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2021 | 3356 | 1.000 |
Why?
|
DNA, Viral | 9 | 2016 | 2201 | 0.990 |
Why?
|
Early Detection of Cancer | 12 | 2020 | 3201 | 0.980 |
Why?
|
Mass Screening | 24 | 2015 | 5428 | 0.870 |
Why?
|
Image Processing, Computer-Assisted | 13 | 2021 | 8999 | 0.830 |
Why?
|
Diagnosis, Computer-Assisted | 6 | 2020 | 710 | 0.730 |
Why?
|
Precancerous Conditions | 6 | 2014 | 980 | 0.720 |
Why?
|
Colposcopy | 6 | 2015 | 150 | 0.720 |
Why?
|
Remote Consultation | 2 | 2014 | 237 | 0.680 |
Why?
|
Microscopy | 7 | 2016 | 903 | 0.640 |
Why?
|
Kidney Glomerulus | 1 | 2021 | 568 | 0.640 |
Why?
|
Specimen Handling | 11 | 2010 | 702 | 0.630 |
Why?
|
Staining and Labeling | 6 | 2021 | 1084 | 0.620 |
Why?
|
Pathology | 3 | 2016 | 270 | 0.620 |
Why?
|
Clinical Competence | 15 | 2013 | 4793 | 0.600 |
Why?
|
Societies, Medical | 27 | 2014 | 3905 | 0.570 |
Why?
|
Sputum | 2 | 2018 | 507 | 0.540 |
Why?
|
Diagnostic Imaging | 4 | 2014 | 3530 | 0.540 |
Why?
|
Condylomata Acuminata | 2 | 2014 | 75 | 0.540 |
Why?
|
Neoplasms, Squamous Cell | 5 | 2013 | 95 | 0.530 |
Why?
|
Sensitivity and Specificity | 31 | 2018 | 14664 | 0.530 |
Why?
|
Practice Guidelines as Topic | 7 | 2015 | 7389 | 0.500 |
Why?
|
Gynecology | 7 | 2015 | 526 | 0.490 |
Why?
|
Vagina | 6 | 2014 | 838 | 0.490 |
Why?
|
False Negative Reactions | 12 | 2011 | 573 | 0.480 |
Why?
|
Educational Measurement | 5 | 2011 | 1254 | 0.470 |
Why?
|
Adenocarcinoma | 14 | 2016 | 6339 | 0.450 |
Why?
|
Carcinoma in Situ | 8 | 2013 | 791 | 0.440 |
Why?
|
Tumor Virus Infections | 3 | 2007 | 438 | 0.420 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 240 | 0.410 |
Why?
|
Carcinoma, Small Cell | 3 | 2010 | 420 | 0.410 |
Why?
|
Female | 112 | 2022 | 392581 | 0.390 |
Why?
|
Biopsy, Fine-Needle | 18 | 2016 | 1118 | 0.380 |
Why?
|
Nucleic Acid Hybridization | 4 | 2010 | 1306 | 0.370 |
Why?
|
Reproducibility of Results | 29 | 2020 | 20093 | 0.370 |
Why?
|
Education, Medical, Continuing | 3 | 2014 | 823 | 0.360 |
Why?
|
Clinical Laboratory Techniques | 5 | 2009 | 746 | 0.360 |
Why?
|
Candida | 2 | 2009 | 172 | 0.350 |
Why?
|
Humans | 149 | 2022 | 761423 | 0.350 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2009 | 25 | 0.330 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2578 | 0.330 |
Why?
|
Research | 1 | 2018 | 1977 | 0.330 |
Why?
|
Laboratories, Hospital | 2 | 2009 | 192 | 0.320 |
Why?
|
Luminescent Measurements | 1 | 2010 | 342 | 0.320 |
Why?
|
Granuloma | 1 | 2010 | 327 | 0.310 |
Why?
|
Diagnosis, Differential | 21 | 2016 | 12970 | 0.290 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2007 | 239 | 0.270 |
Why?
|
Herpes Simplex | 1 | 2009 | 478 | 0.260 |
Why?
|
Antibodies | 2 | 2018 | 2421 | 0.260 |
Why?
|
Immunohistochemistry | 14 | 2018 | 11073 | 0.240 |
Why?
|
Observer Variation | 7 | 2015 | 2605 | 0.240 |
Why?
|
False Positive Reactions | 7 | 2010 | 957 | 0.240 |
Why?
|
North America | 11 | 2009 | 1276 | 0.230 |
Why?
|
Medical Records | 1 | 2009 | 1407 | 0.230 |
Why?
|
Lung Neoplasms | 7 | 2018 | 13337 | 0.220 |
Why?
|
Genital Neoplasms, Female | 5 | 2012 | 532 | 0.220 |
Why?
|
Lymphoproliferative Disorders | 1 | 2006 | 533 | 0.210 |
Why?
|
Internet | 3 | 2015 | 3092 | 0.210 |
Why?
|
Quality Control | 10 | 2005 | 832 | 0.200 |
Why?
|
Carcinoid Tumor | 3 | 2011 | 224 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.200 |
Why?
|
Predictive Value of Tests | 13 | 2020 | 15262 | 0.190 |
Why?
|
Neoplasm Invasiveness | 6 | 2015 | 3589 | 0.190 |
Why?
|
Evaluation Studies as Topic | 6 | 1999 | 1626 | 0.190 |
Why?
|
Antibodies, Neoplasm | 3 | 2007 | 281 | 0.190 |
Why?
|
Man-Machine Systems | 2 | 1998 | 42 | 0.190 |
Why?
|
Uterine Cervicitis | 2 | 1998 | 31 | 0.190 |
Why?
|
Biology | 1 | 2022 | 289 | 0.180 |
Why?
|
Automation, Laboratory | 3 | 2020 | 102 | 0.180 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 2016 | 262 | 0.180 |
Why?
|
Image Cytometry | 1 | 1999 | 54 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2014 | 1085 | 0.160 |
Why?
|
Pneumonia | 1 | 2010 | 2140 | 0.160 |
Why?
|
Coloring Agents | 1 | 2021 | 559 | 0.160 |
Why?
|
Anus Neoplasms | 2 | 2013 | 329 | 0.160 |
Why?
|
Autoanalysis | 1 | 1998 | 71 | 0.160 |
Why?
|
Carcinoma | 5 | 2016 | 2330 | 0.150 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 1998 | 39 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 3 | 2007 | 304 | 0.150 |
Why?
|
Receptors, Progesterone | 2 | 1993 | 1129 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 698 | 0.140 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1997 | 64 | 0.140 |
Why?
|
Biopsy, Needle | 5 | 2015 | 1626 | 0.140 |
Why?
|
Laboratories | 4 | 2015 | 458 | 0.140 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2014 | 926 | 0.140 |
Why?
|
Expert Testimony | 4 | 2006 | 363 | 0.130 |
Why?
|
Thyroid Neoplasms | 5 | 2011 | 2332 | 0.130 |
Why?
|
Manuals as Topic | 1 | 2015 | 99 | 0.130 |
Why?
|
Feasibility Studies | 4 | 2014 | 5246 | 0.130 |
Why?
|
Adenoma, Pleomorphic | 2 | 2007 | 75 | 0.130 |
Why?
|
Risk | 5 | 2011 | 9612 | 0.120 |
Why?
|
Anal Canal | 2 | 2015 | 373 | 0.120 |
Why?
|
Epithelial Cells | 6 | 2016 | 3667 | 0.120 |
Why?
|
Biopsy | 4 | 2021 | 6766 | 0.120 |
Why?
|
Parotid Neoplasms | 1 | 2016 | 157 | 0.120 |
Why?
|
Maryland | 1 | 2015 | 277 | 0.120 |
Why?
|
Workload | 3 | 2020 | 844 | 0.120 |
Why?
|
Computer-Assisted Instruction | 1 | 1998 | 362 | 0.120 |
Why?
|
Workflow | 2 | 2020 | 851 | 0.120 |
Why?
|
Carcinoma, Papillary | 4 | 2011 | 785 | 0.110 |
Why?
|
Receptors, Estrogen | 2 | 1993 | 2208 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2016 | 267 | 0.110 |
Why?
|
Head and Neck Neoplasms | 3 | 2016 | 2892 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 1998 | 422 | 0.110 |
Why?
|
Coitus | 1 | 2014 | 131 | 0.110 |
Why?
|
Gastric Mucosa | 2 | 2007 | 604 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20556 | 0.110 |
Why?
|
United States | 13 | 2015 | 72339 | 0.100 |
Why?
|
Behcet Syndrome | 1 | 1993 | 86 | 0.100 |
Why?
|
Thyroid Gland | 2 | 2011 | 1168 | 0.100 |
Why?
|
Neoplasm Staging | 3 | 2015 | 11106 | 0.100 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2011 | 35 | 0.100 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2015 | 793 | 0.100 |
Why?
|
Urogenital Neoplasms | 1 | 2013 | 131 | 0.100 |
Why?
|
Hyperplasia | 1 | 2014 | 1152 | 0.100 |
Why?
|
Breast Neoplasms | 8 | 2014 | 21012 | 0.090 |
Why?
|
Decision Making | 1 | 2005 | 3929 | 0.090 |
Why?
|
Task Performance and Analysis | 1 | 2015 | 761 | 0.090 |
Why?
|
Learning Curve | 1 | 2013 | 230 | 0.090 |
Why?
|
Hospitals, University | 1 | 2013 | 563 | 0.090 |
Why?
|
Botswana | 1 | 2014 | 1048 | 0.090 |
Why?
|
History, 20th Century | 2 | 2015 | 2769 | 0.090 |
Why?
|
England | 1 | 2012 | 527 | 0.090 |
Why?
|
Papilloma | 1 | 1991 | 140 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 803 | 0.090 |
Why?
|
Efficiency | 1 | 2013 | 476 | 0.080 |
Why?
|
Frozen Sections | 1 | 2010 | 153 | 0.080 |
Why?
|
Salivary Glands | 3 | 2007 | 229 | 0.080 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 2009 | 40 | 0.080 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2013 | 495 | 0.080 |
Why?
|
Software | 3 | 2014 | 4434 | 0.080 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2006 | 323 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1567 | 0.080 |
Why?
|
User-Computer Interface | 2 | 2010 | 1400 | 0.080 |
Why?
|
Pericardial Effusion | 1 | 1991 | 247 | 0.080 |
Why?
|
Allied Health Personnel | 1 | 2010 | 155 | 0.080 |
Why?
|
Paraffin Embedding | 4 | 2016 | 302 | 0.080 |
Why?
|
Immunoenzyme Techniques | 2 | 2008 | 1706 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6086 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1551 | 0.070 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2008 | 122 | 0.070 |
Why?
|
Liver Neoplasms | 3 | 2011 | 4320 | 0.070 |
Why?
|
Tissue Fixation | 3 | 2016 | 241 | 0.070 |
Why?
|
Genome, Viral | 2 | 2003 | 665 | 0.070 |
Why?
|
RNA Probes | 1 | 2006 | 111 | 0.070 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2011 | 339 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3418 | 0.070 |
Why?
|
Breast Diseases | 1 | 1990 | 442 | 0.070 |
Why?
|
Retrospective Studies | 14 | 2015 | 80582 | 0.070 |
Why?
|
Single-Blind Method | 2 | 2002 | 1571 | 0.070 |
Why?
|
Patient Care Management | 1 | 2009 | 302 | 0.070 |
Why?
|
Professional Practice | 1 | 2008 | 313 | 0.070 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2006 | 84 | 0.060 |
Why?
|
Ovary | 1 | 2010 | 959 | 0.060 |
Why?
|
Glucose Transporter Type 1 | 1 | 2006 | 186 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 3687 | 0.060 |
Why?
|
Breast | 1 | 2014 | 1966 | 0.060 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2006 | 89 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2007 | 552 | 0.060 |
Why?
|
Algorithms | 2 | 2004 | 14026 | 0.060 |
Why?
|
Health Policy | 1 | 1998 | 2684 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2007 | 329 | 0.060 |
Why?
|
Thymoma | 1 | 2006 | 187 | 0.060 |
Why?
|
Middle Aged | 17 | 2015 | 220826 | 0.060 |
Why?
|
Equipment Design | 1 | 2013 | 3509 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 1990 | 1745 | 0.060 |
Why?
|
Thyroid Nodule | 1 | 2011 | 764 | 0.060 |
Why?
|
Sexual Partners | 1 | 2009 | 796 | 0.060 |
Why?
|
DNA Probes, HPV | 1 | 2003 | 21 | 0.060 |
Why?
|
Pancreatitis, Chronic | 1 | 2007 | 289 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2006 | 273 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2884 | 0.060 |
Why?
|
Mediastinal Neoplasms | 1 | 2006 | 401 | 0.060 |
Why?
|
Antigens, Neoplasm | 2 | 2008 | 1994 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2006 | 2298 | 0.050 |
Why?
|
Meningioma | 2 | 1989 | 1218 | 0.050 |
Why?
|
Aged | 13 | 2016 | 169235 | 0.050 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 496 | 0.050 |
Why?
|
Hamartoma | 1 | 2005 | 235 | 0.050 |
Why?
|
Computational Biology | 1 | 2014 | 3517 | 0.050 |
Why?
|
Goblet Cells | 1 | 2005 | 298 | 0.050 |
Why?
|
Duodenum | 1 | 2005 | 489 | 0.050 |
Why?
|
Formaldehyde | 2 | 2016 | 358 | 0.050 |
Why?
|
Meningeal Neoplasms | 2 | 1989 | 1248 | 0.050 |
Why?
|
Adult | 16 | 2015 | 221148 | 0.050 |
Why?
|
Health Plan Implementation | 1 | 2004 | 337 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2010 | 39117 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2008 | 14599 | 0.050 |
Why?
|
Adenoma | 1 | 2011 | 2160 | 0.050 |
Why?
|
Flow Cytometry | 2 | 1990 | 5868 | 0.050 |
Why?
|
Atrophy | 2 | 2003 | 1633 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2004 | 727 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 1993 | 4510 | 0.040 |
Why?
|
Reference Standards | 3 | 2013 | 1004 | 0.040 |
Why?
|
Adolescent | 5 | 2014 | 88313 | 0.040 |
Why?
|
Actinomyces | 1 | 1999 | 40 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2014 | 1385 | 0.040 |
Why?
|
Neuroblastoma | 1 | 1988 | 1250 | 0.040 |
Why?
|
Trichomonas vaginalis | 1 | 1999 | 70 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1725 | 0.040 |
Why?
|
Age Factors | 3 | 2012 | 18400 | 0.040 |
Why?
|
Metaplasia | 3 | 2012 | 322 | 0.040 |
Why?
|
Pancreas | 1 | 2005 | 1690 | 0.040 |
Why?
|
Epithelium | 2 | 1996 | 1603 | 0.040 |
Why?
|
Fixatives | 2 | 2016 | 91 | 0.040 |
Why?
|
Information Services | 2 | 1998 | 236 | 0.040 |
Why?
|
Leukemia | 1 | 2006 | 1522 | 0.040 |
Why?
|
Social Responsibility | 2 | 1998 | 386 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1496 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5869 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 1993 | 3163 | 0.040 |
Why?
|
Databases, Factual | 3 | 2015 | 7956 | 0.040 |
Why?
|
Bone Marrow | 1 | 1988 | 2910 | 0.040 |
Why?
|
Lymphoma | 1 | 2006 | 1901 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 3447 | 0.030 |
Why?
|
Estrogens | 1 | 2003 | 1522 | 0.030 |
Why?
|
Histocytological Preparation Techniques | 1 | 1996 | 33 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 1993 | 4248 | 0.030 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2016 | 109 | 0.030 |
Why?
|
Consensus | 1 | 2006 | 3122 | 0.030 |
Why?
|
DNA | 1 | 1990 | 7219 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2007 | 3030 | 0.030 |
Why?
|
Simplexvirus | 1 | 1999 | 803 | 0.030 |
Why?
|
Computer Graphics | 1 | 1998 | 340 | 0.030 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2007 | 1726 | 0.030 |
Why?
|
Odds Ratio | 1 | 2008 | 9645 | 0.030 |
Why?
|
Laboratory Proficiency Testing | 1 | 2015 | 20 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 1988 | 2529 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 728 | 0.030 |
Why?
|
Time Factors | 2 | 2013 | 39975 | 0.030 |
Why?
|
Risk Factors | 5 | 2009 | 74167 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2006 | 3466 | 0.030 |
Why?
|
Cell Nucleus | 4 | 2006 | 2908 | 0.030 |
Why?
|
Mitotic Index | 1 | 1995 | 162 | 0.030 |
Why?
|
Male | 11 | 2016 | 360736 | 0.030 |
Why?
|
Prognosis | 5 | 2014 | 29620 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2016 | 340 | 0.030 |
Why?
|
Ploidies | 2 | 1996 | 285 | 0.030 |
Why?
|
Sampling Studies | 1 | 2015 | 615 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2007 | 9179 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2014 | 162 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5794 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2002 | 8000 | 0.030 |
Why?
|
American Cancer Society | 1 | 2012 | 69 | 0.030 |
Why?
|
Cohort Studies | 1 | 2015 | 41446 | 0.030 |
Why?
|
Paraffin | 1 | 1992 | 37 | 0.030 |
Why?
|
Vulva | 1 | 2012 | 84 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.020 |
Why?
|
Wales | 1 | 2011 | 87 | 0.020 |
Why?
|
Charcoal | 1 | 1992 | 67 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 1993 | 9031 | 0.020 |
Why?
|
Massachusetts | 2 | 2015 | 8832 | 0.020 |
Why?
|
Pericardial Window Techniques | 1 | 1991 | 10 | 0.020 |
Why?
|
Risk Assessment | 2 | 2013 | 23990 | 0.020 |
Why?
|
Menstruation | 1 | 1993 | 307 | 0.020 |
Why?
|
Hospitals, General | 1 | 2015 | 798 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2014 | 328 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9606 | 0.020 |
Why?
|
Research Personnel | 1 | 2015 | 588 | 0.020 |
Why?
|
Child, Preschool | 2 | 2007 | 42254 | 0.020 |
Why?
|
Prospective Studies | 5 | 1999 | 54415 | 0.020 |
Why?
|
Young Adult | 3 | 2015 | 59207 | 0.020 |
Why?
|
Dextrans | 1 | 1992 | 574 | 0.020 |
Why?
|
RNA, Viral | 2 | 1988 | 2846 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1997 | 2914 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2007 | 5365 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 1998 | 1664 | 0.020 |
Why?
|
S100 Proteins | 1 | 1989 | 218 | 0.020 |
Why?
|
Neoplasms | 2 | 2004 | 22164 | 0.020 |
Why?
|
Risk Management | 1 | 2012 | 558 | 0.020 |
Why?
|
Vimentin | 1 | 1989 | 255 | 0.020 |
Why?
|
Molluscum Contagiosum | 1 | 1988 | 15 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1156 | 0.020 |
Why?
|
Phycoerythrin | 1 | 1988 | 9 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1989 | 698 | 0.020 |
Why?
|
Psychometrics | 1 | 1998 | 3065 | 0.020 |
Why?
|
Keratins | 1 | 1989 | 497 | 0.020 |
Why?
|
Immunoblotting | 1 | 1991 | 1647 | 0.020 |
Why?
|
Genital Diseases, Female | 1 | 2009 | 192 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17347 | 0.020 |
Why?
|
Cytoplasm | 2 | 2005 | 1511 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2005 | 22168 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1458 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3580 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2007 | 26212 | 0.020 |
Why?
|
Physical Examination | 1 | 1993 | 1254 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 5302 | 0.020 |
Why?
|
Endometrium | 1 | 2009 | 403 | 0.020 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2006 | 34 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1989 | 2561 | 0.020 |
Why?
|
Cytoplasmic Structures | 1 | 2005 | 21 | 0.020 |
Why?
|
Capsid | 1 | 1988 | 435 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2016 | 2985 | 0.020 |
Why?
|
Infant | 1 | 2007 | 36205 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3322 | 0.010 |
Why?
|
Mucin-1 | 1 | 1989 | 540 | 0.010 |
Why?
|
Child | 2 | 2007 | 80162 | 0.010 |
Why?
|
Chromatin | 2 | 2006 | 2960 | 0.010 |
Why?
|
Antigens, Viral | 1 | 1988 | 988 | 0.010 |
Why?
|
Pilot Projects | 1 | 1997 | 8633 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1988 | 12796 | 0.010 |
Why?
|
Body Fluids | 1 | 2004 | 320 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 1993 | 2557 | 0.010 |
Why?
|
Endosonography | 1 | 2005 | 609 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1988 | 2415 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 1993 | 3889 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1993 | 3204 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9330 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1989 | 3702 | 0.010 |
Why?
|
Cerebral Infarction | 1 | 1983 | 983 | 0.010 |
Why?
|
Exocrine Glands | 1 | 1998 | 46 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 1998 | 36423 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2013 | 58956 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 1988 | 4912 | 0.010 |
Why?
|
New York | 1 | 1998 | 874 | 0.010 |
Why?
|
Palliative Care | 1 | 1991 | 3600 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15717 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26112 | 0.010 |
Why?
|
Truth Disclosure | 1 | 1998 | 434 | 0.010 |
Why?
|
Heart Arrest | 1 | 1983 | 1514 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1988 | 18964 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8545 | 0.010 |
Why?
|
Hysterectomy | 1 | 1996 | 857 | 0.010 |
Why?
|
Obesity | 1 | 1993 | 12938 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1975 | 1560 | 0.010 |
Why?
|
Mastectomy | 1 | 1997 | 1822 | 0.000 |
Why?
|
Pelvis | 1 | 1993 | 732 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1989 | 513 | 0.000 |
Why?
|
Organizational Objectives | 1 | 1989 | 426 | 0.000 |
Why?
|
Animals | 1 | 1999 | 168441 | 0.000 |
Why?
|
Mammography | 1 | 1998 | 2430 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1998 | 5492 | 0.000 |
Why?
|
Kidney Failure, Chronic | 1 | 1975 | 2471 | 0.000 |
Why?
|
Physician-Patient Relations | 1 | 1993 | 3249 | 0.000 |
Why?
|
Necrosis | 1 | 1983 | 1608 | 0.000 |
Why?
|
Dinitrochlorobenzene | 1 | 1975 | 18 | 0.000 |
Why?
|
Hypersensitivity, Delayed | 1 | 1975 | 490 | 0.000 |
Why?
|
Peritoneal Dialysis | 1 | 1975 | 159 | 0.000 |
Why?
|
Skin Tests | 1 | 1975 | 637 | 0.000 |
Why?
|
Antigens | 1 | 1975 | 1446 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1975 | 4808 | 0.000 |
Why?
|
Renal Dialysis | 1 | 1975 | 1797 | 0.000 |
Why?
|
Kidney Transplantation | 1 | 1975 | 4234 | 0.000 |
Why?
|